tradingkey.logo

Becton Dickinson and Co

BDX

222.810USD

-1.010-0.45%
Close 03/13, 16:00ETQuotes delayed by 15 min
64.41BMarket Cap
37.30P/E TTM

Becton Dickinson and Co

222.810

-1.010-0.45%
More Details of Becton Dickinson and Co Company
Company Info
Company codeBDX
Company nameBecton Dickinson and Co
IPO dateSep 25, 1963
Founded at1906
CEOMr. Thomas E. Polen
Number of employees74000
Security typeOrdinary Share
Fiscal year-endSep 25
AddressOne Becton Drive
CityFRANKLIN LAKES
Stock exchangeNYSE Consolidated
CountryUnited States of America
Postal code07417-1880
Phone12018476800
Websitehttps://www.bd.com/
Company codeBDX
IPO dateSep 25, 1963
Founded at1906
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Richard (Rick) Byrd
Mr. Richard (Rick) Byrd
Executive Vice President, President - Interventional Segment
Executive Vice President, President - Interventional Segment
757.04K
+19.29K%
Mr. Timothy M. (Tim) Ring
Mr. Timothy M. (Tim) Ring
Independent Director
Independent Director
59.86K
+1.58%
Ms. Shana Carol Neal
Ms. Shana Carol Neal
Chief People Officer, Executive Vice President
Chief People Officer, Executive Vice President
48.90K
-3.12%
Ms. Catherine M. (Cathy) Burzik
Ms. Catherine M. (Cathy) Burzik
Independent Director
Independent Director
14.80K
+6.70%
Mr. Roland Goette
Mr. Roland Goette
Executive Vice President, President - EMEA
Executive Vice President, President - EMEA
14.20K
-8.25%
Mr. Antoine C. Ezell
Mr. Antoine C. Ezell
Executive Vice President, President, North America, Chief Marketing Officer
Executive Vice President, President, North America, Chief Marketing Officer
11.97K
+28.43%
Mr. Michael Feld
Mr. Michael Feld
Executive Vice President, President - Life Sciences
Executive Vice President, President - Life Sciences
9.19K
+38.45%
Mr. Robert Andrew (Andy) Eckert
Mr. Robert Andrew (Andy) Eckert
Independent Director
Independent Director
9.13K
+11.33%
Ms. Michelle Quinn
Ms. Michelle Quinn
Executive Vice President, General Counsel
Executive Vice President, General Counsel
6.92K
+39.79%
Dr. Carrie L. Byington, M.D.
Dr. Carrie L. Byington, M.D.
Independent Director
Independent Director
5.24K
+21.54%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Richard (Rick) Byrd
Mr. Richard (Rick) Byrd
Executive Vice President, President - Interventional Segment
Executive Vice President, President - Interventional Segment
757.04K
+19.29K%
Mr. Timothy M. (Tim) Ring
Mr. Timothy M. (Tim) Ring
Independent Director
Independent Director
59.86K
+1.58%
Ms. Shana Carol Neal
Ms. Shana Carol Neal
Chief People Officer, Executive Vice President
Chief People Officer, Executive Vice President
48.90K
-3.12%
Ms. Catherine M. (Cathy) Burzik
Ms. Catherine M. (Cathy) Burzik
Independent Director
Independent Director
14.80K
+6.70%
Mr. Roland Goette
Mr. Roland Goette
Executive Vice President, President - EMEA
Executive Vice President, President - EMEA
14.20K
-8.25%
Mr. Antoine C. Ezell
Mr. Antoine C. Ezell
Executive Vice President, President, North America, Chief Marketing Officer
Executive Vice President, President, North America, Chief Marketing Officer
11.97K
+28.43%
Revenue Breakdown
Currency: USDUpdate time: Wed, Mar 5
Currency: USDUpdate time: Wed, Mar 5
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Medication Delivery Solutions
1.12B
21.74%
Medication Management Solutions
801.00M
15.49%
Integrated Diagnostic Solutions
474.00M
9.17%
Peripheral Intervention
473.00M
9.15%
Specimen Management
462.00M
8.93%
Other
1.83B
35.48%
By RegionUSD
Name
Revenue
Proportion
United States
3.07B
59.57%
International
2.08B
40.42%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Medication Delivery Solutions
1.12B
21.74%
Medication Management Solutions
801.00M
15.49%
Integrated Diagnostic Solutions
474.00M
9.17%
Peripheral Intervention
473.00M
9.15%
Specimen Management
462.00M
8.93%
Other
1.83B
35.48%
Shareholder
Update time: Fri, Feb 21
Update time: Fri, Feb 21
Shareholder Statistics
Type
Shareholder Statistics
Shareholder
Proportion
The Vanguard Group, Inc.
9.26%
BlackRock Institutional Trust Company, N.A.
5.15%
State Street Global Advisors (US)
4.90%
T. Rowe Price Investment Management, Inc.
4.22%
T. Rowe Price Associates, Inc.
4.15%
Other
72.28%
Shareholder Statistics
Shareholder
Proportion
The Vanguard Group, Inc.
9.26%
BlackRock Institutional Trust Company, N.A.
5.15%
State Street Global Advisors (US)
4.90%
T. Rowe Price Investment Management, Inc.
4.22%
T. Rowe Price Associates, Inc.
4.15%
Other
72.28%
Type
Shareholder
Proportion
Investment Advisor/Hedge Fund
41.50%
Investment Advisor
41.05%
Pension Fund
2.87%
Hedge Fund
2.49%
Research Firm
2.45%
Bank and Trust
1.65%
Sovereign Wealth Fund
1.23%
Individual Investor
0.56%
Insurance Company
0.28%
Other
5.86%
Institutional Shareholding
Update time: Sun, Jan 19
Update time: Sun, Jan 19
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q1
2786
271.52M
94.56%
-4.48M
2024Q4
2874
271.53M
94.56%
-4.61M
2024Q3
2787
266.28M
92.14%
-3.20M
2024Q2
2782
261.00M
90.31%
-2.67M
2024Q1
2797
255.98M
88.58%
-10.13M
2023Q4
2783
259.38M
89.78%
-7.78M
2023Q3
2768
264.63M
91.23%
-591.86K
2023Q2
2787
263.28M
90.78%
-570.63K
2023Q1
2795
257.22M
90.56%
-8.75M
2022Q4
2831
255.71M
90.07%
-14.75M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
26.61M
9.26%
+188.34K
+0.71%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
14.81M
5.15%
+196.27K
+1.34%
Dec 31, 2024
State Street Global Advisors (US)
14.08M
4.9%
+134.35K
+0.96%
Dec 31, 2024
T. Rowe Price Investment Management, Inc.
12.12M
4.22%
+3.21M
+36.14%
Dec 31, 2024
T. Rowe Price Associates, Inc.
11.92M
4.15%
-1.15M
-8.83%
Dec 31, 2024
Geode Capital Management, L.L.C.
6.35M
2.21%
+66.02K
+1.05%
Dec 31, 2024
Generation Investment Management LLP
5.81M
2.02%
-139.25K
-2.33%
Dec 31, 2024
Morgan Stanley Investment Management Ltd. (UK)
5.69M
1.98%
-310.27K
-5.16%
Dec 31, 2024
MFS Investment Management
5.45M
1.89%
+708.73K
+14.93%
Dec 31, 2024
First Eagle Investment Management, L.L.C.
4.43M
1.54%
+1.05M
+31.36%
Dec 31, 2024
View more
Related ETFs
Update time: Thu, Mar 6
Update time: Thu, Mar 6
Name
Proportion
iShares U.S. Medical Devices ETF
5.07%
T Rowe Price Capital Appreciation Equity ETF
3.49%
Brookstone Value Stock ETF
3.41%
ClearBridge Dividend Strategy ESG ETF
3.05%
Natixis Vaughan Nelson Select ETF
2.6%
American Century Focused Large Cap Value ETF
2.49%
Touchstone US Large Cap Focused ETF
2.39%
First Trust Indxx Medical Devices ETF
2.18%
ProShares MSCI Transformational Changes ETF
2.1%
SPDR S&P Health Care Equipment ETF
1.94%
View more
iShares U.S. Medical Devices ETF
Proportion5.07%
T Rowe Price Capital Appreciation Equity ETF
Proportion3.49%
Brookstone Value Stock ETF
Proportion3.41%
ClearBridge Dividend Strategy ESG ETF
Proportion3.05%
Natixis Vaughan Nelson Select ETF
Proportion2.6%
American Century Focused Large Cap Value ETF
Proportion2.49%
Touchstone US Large Cap Focused ETF
Proportion2.39%
First Trust Indxx Medical Devices ETF
Proportion2.18%
ProShares MSCI Transformational Changes ETF
Proportion2.1%
SPDR S&P Health Care Equipment ETF
Proportion1.94%
Dividend
A total of 5.33B USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
Jan 28, 2025
BDX.NB Interim Cash Dividend of gross USD 1.04 paid on Mar 31, 2025 going ex on Mar 10, 2025
Mar 10, 2025
Mar 31, 2025
Mar 10, 2025
Nov 07, 2024
BDX.NB Final Cash Dividend of gross USD 1.04 paid on Dec 31, 2024 going ex on Dec 09, 2024
Dec 09, 2024
Dec 31, 2024
Dec 09, 2024
Jul 23, 2024
BDX.NB Interim Cash Dividend of gross USD 0.95 paid on Sep 30, 2024 going ex on Sep 09, 2024
Sep 09, 2024
Sep 30, 2024
Sep 09, 2024
Apr 30, 2024
BDX.NB Interim Cash Dividend of gross USD 0.95 paid on Jun 28, 2024 going ex on Jun 10, 2024
Jun 10, 2024
Jun 28, 2024
Jun 10, 2024
Jan 23, 2024
BDX.NB Interim Cash Dividend of gross USD 0.95 paid on Mar 29, 2024 going ex on Mar 07, 2024
Mar 08, 2024
Mar 29, 2024
Mar 07, 2024
Nov 09, 2023
BDX.NB Final Cash Dividend of gross USD 0.95 paid on Dec 29, 2023 going ex on Dec 07, 2023
Dec 08, 2023
Dec 29, 2023
Dec 07, 2023
Jul 25, 2023
BDX.NB Interim Cash Dividend of gross USD 0.91 paid on Sep 29, 2023 going ex on Sep 07, 2023
Sep 08, 2023
Sep 29, 2023
Sep 07, 2023
Apr 25, 2023
BDX.NB Interim Cash Dividend of gross USD 0.91 paid on Jun 30, 2023 going ex on Jun 08, 2023
Jun 09, 2023
Jun 30, 2023
Jun 08, 2023
Jan 24, 2023
BDX.NB Interim Cash Dividend of gross USD 0.91 paid on Mar 31, 2023 going ex on Mar 09, 2023
Mar 10, 2023
Mar 31, 2023
Mar 09, 2023
Nov 10, 2022
BDX.NB Final Cash Dividend of gross USD 0.91 paid on Dec 30, 2022 going ex on Dec 08, 2022
Dec 09, 2022
Dec 30, 2022
Dec 08, 2022
View more
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
tradingkey.logo
tradingkey.logo
Intraday Data provided by Refinitiv and subject to terms of use. Historical and current end-of-day data provided by Refinitiv. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.
* References, analysis, and trading strategies are provided by the third-party provider, Trading Central, and the point of view is based on the independent assessment and judgement of the analyst, without considering the investment objectives and financial situation of the investors.
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.